[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638277":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":26,"studyPopulation":26,"armGroups":38,"interventions":51,"overallOfficials":26,"centralContacts":60,"locations":66,"responsibleParty":82,"collaborators":84,"id":88,"slug":26,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":26,"eligibilityCriteria":93,"healthyVolunteers":94,"sex":95,"minAge":96,"maxAge":97,"enrollmentInfo":98,"targetDuration":26,"studyType":101,"phases":102,"briefSummary":104,"conditions":105,"keywords":26,"overallStatus":107,"whyStopped":26,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"University of California, Riverside","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"Hemoglobin A1C","Change in Ha1c from baseline to 3 months. To test the efficacy of the A1Cantus drink in improving glycemic control in patients with Type II Diabetes","3 months",[14,17,20,23],{"measure":15,"description":16,"timeFrame":12},"Change in A1C","Percentage of participants whose A1C was lowered from Baseline to 3 months",{"measure":18,"description":19,"timeFrame":12},"Hypertension","Change in systolic and diastolic blood pressure from baseline to three months",{"measure":21,"description":22,"timeFrame":12},"Body Mass Index (BMI)","Change in body mass index from baseline to 3 months",{"measure":24,"description":25,"timeFrame":12},"Cholesterol","Change in fasting LDL and HDL from baseline to three months",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":26,"primaryPurpose":30,"observationalModel":26,"timePerspective":26,"maskingInfo":31},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":32,"maskingDescription":26,"whoMasked":33},"QUADRUPLE",[34,35,36,37],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[39,45],{"label":40,"type":41,"description":42,"interventionNames":43},"Placebo Drink","PLACEBO_COMPARATOR","The placebo drink will be formulated to closely match the active drink in taste, color and mouthfeel, while removing all active ingredients.",[44],"Other: Placebo drink",{"label":46,"type":47,"description":48,"interventionNames":49},"A1C Drink","EXPERIMENTAL","The A1C drink is currently on the market with natural active ingredients.",[50],"Dietary Supplement: A1C Drink",[52,56],{"type":53,"name":46,"description":54,"armGroupLabels":55,"otherNames":26},"DIETARY_SUPPLEMENT","In the experimental arm, participants will drink the A1C drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.",[46],{"type":6,"name":57,"description":58,"armGroupLabels":59,"otherNames":26},"Placebo drink","In the placebo arm, participants will drink the placebo drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.",[40],[61],{"name":62,"role":63,"phone":64,"phoneExt":26,"email":65},"Elizabeth Jacobs, MD, MPP","CONTACT","951-827-8643","elizabeth.jacobs@medsch.ucr.edu",[67],{"facility":68,"status":26,"city":69,"state":70,"zip":71,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":79,"contacts":80},"UCR Health","Riverside","California","92521","United States","US",{"type":75,"coordinates":76},"Point",[77,78],-117.39616,33.95335,{"lat":78,"lon":77},[81],{"name":62,"role":63,"phone":64,"phoneExt":26,"email":65},{"type":83,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[85],{"name":86,"class":87},"A1Cantus","UNKNOWN","100638277",false,"NCT07585630","A1Cantus vs. Placebo","Double-Blind Randomized Controlled Trial of A1Cantus Drink vs. Placebo for Reduction of Ha1c","Inclusion Criteria:\n\n* Adults 21 years of age or older and not older than 75 recruited from UCR Health\n* Clinical diagnosis of type II DM with Ha1c \\>= 8 but less than or equal to 10\n* Stable medications for at least 6 months\n* Speak Spanish and\u002For English\n* Sign an informed consent form\n* No other members in their household are participating in the study\n\nExclusion Criteria:\n\n* Patients \\\u003C21 years of age, who do not have type II DM, whose Ha1c is less than 8 or \\> 10,\n* Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk \\> 5, or history of CVD\u002Fstroke\n* Do not speak and understand either English or Spanish well\n* Allergic to cinnamon\n* Severe diseases, such as cancer\n* Compromised immune system\n* Eating disorders\n* BMI of 40 or higher\n* Already have a family member participating in the study\n* Substance use disorder",true,"ALL","21 Years","75 Years",{"count":99,"type":100},50,"ESTIMATED","INTERVENTIONAL",[103],"PHASE2","The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.",[106],"Type 2 Diabetes","NOT_YET_RECRUITING","2026-05-13",{"date":110,"type":111},"2026-05-18","ACTUAL",{"date":113,"type":100},"2026-06-15",{"date":115,"type":100},"2028-06-01",{"name":5,"class":6},1]